The Obama administration has released its fiscal year 2017 budget request, which aims to shape federal policy by promoting the President’s fiscal recommendations and fiscal priorities, and conveys his spending and tax policy recommendations to Congress.

In the FY 2017 request, the administration recommended $33.136 billion for the National Institutes of Health (NIH), with $1.9 billion of those funds designated to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Kidney disease research is funded through the NIDDK. The President’s 2017 budget requested $438 million for kidney research—a decrease of $1.1 million dollars from the enacted FY 2016 funding level.

The President’s budget also requests that funds focus on three major kidney disease research initiatives:

  • $3.9 million for Pilot Studies of Candidate Therapies for Pediatric Chronic Kidney Disease: This initiative will establish a multicenter collaboration to perform pilot trials to optimize study designs for larger trials of new pediatric CKD treatments.
  • $3 million for APOL1 Gene Variants in Patients Undergoing Kidney Transplantation: This initiative will support a multicenter study of African-American kidney donors and recipients, including evaluation of APOL1 genotypes and transplant outcomes.
  • $1 million for Beyond Histology—Conquering the Heterogeneity within the Renal Biopsy: This initiative will provide research tools to help identify unique molecular signatures in biopsied kidney tissue to further understanding of the normal diseased kidney.